239 related articles for article (PubMed ID: 36568222)
1. The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer.
Jovanovic D; Yan S; Baumgartner M
Front Oncol; 2022; 12():1059513. PubMed ID: 36568222
[TBL] [Abstract][Full Text] [Related]
2. The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma.
Santhana Kumar K; Tripolitsioti D; Ma M; Grählert J; Egli KB; Fiaschetti G; Shalaby T; Grotzer MA; Baumgartner M
Springerplus; 2015; 4():19. PubMed ID: 25625039
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Theileria annulata promote invasive cell motility through kinase regulation of the host actin cytoskeleton.
Ma M; Baumgartner M
PLoS Pathog; 2014 Mar; 10(3):e1004003. PubMed ID: 24626571
[TBL] [Abstract][Full Text] [Related]
4. Morphed and moving: TNFα-driven motility promotes cell dissemination through MAP4K4-induced cytoskeleton remodeling.
Ma M; Baumgartner M
Microb Cell; 2014 Apr; 1(5):154-157. PubMed ID: 28357238
[TBL] [Abstract][Full Text] [Related]
5. Molecular Insights of MAP4K4 Signaling in Inflammatory and Malignant Diseases.
Singh SK; Roy R; Kumar S; Srivastava P; Jha S; Rana B; Rana A
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190200
[TBL] [Abstract][Full Text] [Related]
6. MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Fuller SJ; Edmunds NS; McGuffin LJ; Hardyman MA; Cull JJ; Alharbi HO; Meijles DN; Sugden PH; Clerk A
Biochem J; 2021 Jun; 478(11):2121-2143. PubMed ID: 34032269
[TBL] [Abstract][Full Text] [Related]
7. MAP4K4 and cancer: ready for the main stage?
González-Montero J; Rojas CI; Burotto M
Front Oncol; 2023; 13():1162835. PubMed ID: 37223681
[TBL] [Abstract][Full Text] [Related]
8. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
9. The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons.
Larhammar M; Huntwork-Rodriguez S; Rudhard Y; Sengupta-Ghosh A; Lewcock JW
J Neurosci; 2017 Nov; 37(46):11074-11084. PubMed ID: 28993483
[TBL] [Abstract][Full Text] [Related]
10. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase.
Collins CS; Hong J; Sapinoso L; Zhou Y; Liu Z; Micklash K; Schultz PG; Hampton GM
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3775-80. PubMed ID: 16537454
[TBL] [Abstract][Full Text] [Related]
11. MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.
Tripolitsioti D; Kumar KS; Neve A; Migliavacca J; Capdeville C; Rushing EJ; Ma M; Kijima N; Sharma A; Pruschy M; McComb S; Taylor MD; Grotzer MA; Baumgartner M
Oncotarget; 2018 May; 9(33):23220-23236. PubMed ID: 29796184
[TBL] [Abstract][Full Text] [Related]
12. MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K; Zierath JR
J Biol Chem; 2007 Mar; 282(11):7783-9. PubMed ID: 17227768
[TBL] [Abstract][Full Text] [Related]
13. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
[TBL] [Abstract][Full Text] [Related]
14. MAP4K4 is involved in the neuronal development of retinal photoreceptors.
Huang H; Kuang X; Zou Y; Zeng J; Du H; Tang H; Long C; Mao Y; Yu X; Wen C; Yan J; Shen H
Exp Eye Res; 2023 Aug; 233():109524. PubMed ID: 37290629
[TBL] [Abstract][Full Text] [Related]
15. MAP4K4: an emerging therapeutic target in cancer.
Gao X; Gao C; Liu G; Hu J
Cell Biosci; 2016; 6():56. PubMed ID: 27800153
[TBL] [Abstract][Full Text] [Related]
16. Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation.
Wang M; Amano SU; Flach RJ; Chawla A; Aouadi M; Czech MP
Mol Cell Biol; 2013 Feb; 33(4):678-87. PubMed ID: 23207904
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase.
Machida N; Umikawa M; Takei K; Sakima N; Myagmar BE; Taira K; Uezato H; Ogawa Y; Kariya K
J Biol Chem; 2004 Apr; 279(16):15711-4. PubMed ID: 14966141
[TBL] [Abstract][Full Text] [Related]
18. Cooperation of Striatin 3 and MAP4K4 promotes growth and tissue invasion.
Migliavacca J; Züllig B; Capdeville C; Grotzer MA; Baumgartner M
Commun Biol; 2022 Aug; 5(1):795. PubMed ID: 35941177
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2.
Tesz GJ; Guilherme A; Guntur KV; Hubbard AC; Tang X; Chawla A; Czech MP
J Biol Chem; 2007 Jul; 282(27):19302-12. PubMed ID: 17500068
[TBL] [Abstract][Full Text] [Related]
20. Role of Mitogen-activated protein kinase kinase kinase kinase 4 signaling in liver and metabolic diseases.
Ampadu F; Awasthi V; Joshi AD
J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38844365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
